Yong‐Hong Xu
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 8
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 9
-
- Immune cells in cancer 8
- Phagocytosis and Immune Regulation 3
-
- Diamond and Carbon-based Materials Research 4
- Boron and Carbon Nanomaterials Research 2
-
- Cancer Immunotherapy and Biomarkers 4
-
- Photodynamic Therapy Research Studies 3
- Co-authors
- Li ZhaoNaoki KomatsuXiao ChenFumio WatariKe LiShigeaki AbeTsukasa AkasakaTong‐Fei Li
- Journals
- Biomaterials (3 papers)Advanced Functional Materials (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- ChinaJapanSouth Korea
In The Last Decade
Yong‐Hong Xu
23 papers receiving 884 citations
Peers
Comparison fields: 5 of 81
- Biomaterials 245
- Biomedical Engineering 446
- Immunology 192
- Materials Chemistry 291
- Oncology 158
Countries citing papers authored by Yong‐Hong Xu
This map shows the geographic impact of Yong‐Hong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Hong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Hong Xu more than expected).
Fields of papers citing papers by Yong‐Hong Xu
This network shows the impact of papers produced by Yong‐Hong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Hong Xu. The network helps show where Yong‐Hong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yong‐Hong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 49 | |
| 5 | 2022 | 36 | |
| 6 | 2021 | 44 | |
| 7 | 2021 | 35 | |
| 8 | 2020 | 30 | |
| 9 | 2019 | 61 | |
| 10 | 2019 | 64 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 99 | |
| 13 | 2017 | 77 | |
| 14 | 2015 | 2 | |
| 15 | 2014 | 22 | |
| 16 | 2014 | 145 | |
| 17 | 2014 | 99 | |
| 18 | 2010 | 3 | |
| 19 | 2009 | 31 | |
| 20 | 2008 | 2 |
About Yong‐Hong Xu
Yong‐Hong Xu is a scholar working on Biomaterials, Immunology and Oncology, having authored 23 papers that have together received 891 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (8 papers), Immune cells in cancer (8 papers), Diamond and Carbon-based Materials Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Photodynamic Therapy Research Studies (3 papers), Phagocytosis and Immune Regulation (3 papers) and Boron and Carbon Nanomaterials Research (2 papers). The work is most often cited by research in Biomaterials (245 citations), Biomedical Engineering (446 citations) and Immunology (192 citations). Yong‐Hong Xu has collaborated with scholars based in China, Japan and South Korea. Frequent co-authors include Li Zhao, Naoki Komatsu, Xiao Chen, Fumio Watari, Ke Li, Shigeaki Abe, Tsukasa Akasaka, Tong‐Fei Li, Hua‐Zhen Xu and Min Ho Han. Their work appears in journals such as Biomaterials, Advanced Functional Materials and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.